Pharmacological Management of Gastro-Oesophageal Reflux Disease (Q39475567)

12 September 2017

1 reference

title

Pharmacological management of gastro-oesophageal reflux disease (English)

1 reference

12 September 2017

Pharmacological Management of Gastro-Oesophageal Reflux Disease (English)

1 reference

10.2165/00003495-199549050-00005

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199549050-00005

7 June 2024

author name string

E. C. Klinkenberg-Knol

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7601011

7 June 2024

H. P. Festen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7601011

7 June 2024

S. G. Meuwissen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7601011

7 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7601011

7 June 2024

publication date

1 May 1995

1 reference

12 September 2017

1 reference

12 September 2017

volume

49

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

695-710

1 reference

12 September 2017

1 reference

12 December 2020

Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux oesophagitis?

1 reference

12 December 2020

Cisapride and cimetidine in the treatment of erosive esophagitis

1 reference

12 December 2020

Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux

1 reference

12 December 2020

Famotidine in the management of acid-reflux oesophagitis: a multicentre study

1 reference

12 December 2020

Current concepts of the antireflux barrier

1 reference

12 December 2020

Temporary cessation of long-term maintenance treatment with omeprazole in patients with H2-receptor-antagonist-resistant reflux oesophagitis. Effects on symptoms, endoscopy, serum gastrin, and gastric acid output

1 reference

12 December 2020

Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.

1 reference

12 December 2020

Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis

1 reference

12 December 2020

Symptomatic effect of a low-dose antacid regimen in reflux oesophagitis

1 reference

12 December 2020

Argyrophil cell hyperplasia associated with chronic corpus gastritis in gastric ulcer disease.

1 reference

12 December 2020

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

1 reference

12 December 2020

Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis

1 reference

12 December 2020

Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis

1 reference

12 December 2020

Safety of proton pump inhibitors--an overview

1 reference

12 December 2020

Combination therapy of sucralfate and ranitidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis

1 reference

12 December 2020

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

1 reference

12 December 2020

Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial

1 reference

12 December 2020

Comparison between ranitidine and cimetidine in the treatment of reflux oesophagitis

1 reference

12 December 2020

Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial

1 reference

12 December 2020

Surgery for uncomplicated gastrooesophageal reflux

1 reference

12 December 2020

Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.

1 reference

12 December 2020

Omeprazole. Overview and opinion

1 reference

12 December 2020

Sucralfate versus cimetidine in reflux oesophagitis. A double-blind clinical study

1 reference

12 December 2020

Cimetidine and metoclopramide in oesophageal reflux disease.

1 reference

12 December 2020

Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study.

1 reference

12 December 2020

Rationale and Efficacy of Conservative Therapy for Gastroesophageal Reflux Disease

1 reference

12 December 2020

Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study

1 reference

12 December 2020

Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole

1 reference

12 December 2020

Treatment of erosive reflux oesophagitis: a double-blind multicentre trial with nizatidine 300 mg b.i.d. versus placebo

1 reference

12 December 2020

Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole

1 reference

12 December 2020

Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study Group

1 reference

12 December 2020

Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis

1 reference

12 December 2020

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

1 reference

12 December 2020

Ranitidine for erosive oesophagitis: a double-blind, placebo-controlled study. Glaxo Erosive Esophagitis Study Group

1 reference

12 December 2020

Ranitidine, 150 mg three times a day, in the treatment of reflux oesophagitis. A placebo-controlled, double-blind study

1 reference

12 December 2020

Effect of cisapride on relapse of esophagitis. A multinational, placebo-controlled trial in patients healed with an antisecretory drug. The Italian Eurocis Trialists

1 reference

12 December 2020

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

1 reference

12 December 2020

Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis.

1 reference

12 December 2020

Esophagitis healing with ranitidine.

1 reference

12 December 2020

Healing of grade-II and III oesophagitis through motility stimulation with cisapride

1 reference

12 December 2020

Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats.

1 reference

12 December 2020

Treatment of reflux oesophagitis with H2-receptor antagonists

1 reference

12 December 2020

Effect of cimetidine in symptomatic gastro-oesophageal reflux

1 reference

12 December 2020

The spectrum of the symptoms and presentations of gastroesophageal reflux disease

1 reference

12 December 2020

Healing and prevention of relapse of reflux oesophagitis by cisapride

1 reference

12 December 2020

Healing and relapse of severe peptic esophagitis after treatment with omeprazole

1 reference

12 December 2020

Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis

1 reference

12 December 2020

Ranitidine and high-dose antacid in reflux oesophagitis. A randomized, placebo-controlled trial

1 reference

12 December 2020

Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine

1 reference

12 December 2020

Ranitidine in the treatment of symptomatic gastroesophageal reflux disease

1 reference

12 December 2020

Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group

1 reference

12 December 2020

Cimetidine in the treatment of symptomatic gastroesophageal reflux: a double blind controlled trial

1 reference

12 December 2020

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

1 reference

12 December 2020

Postmarketing surveillance of the safety of cimetidine: 10 year mortality report

1 reference

12 December 2020

Medical therapy for gastroesophageal reflux disease. Not all treatments are equal!

1 reference

12 December 2020

Current trends in the pharmacotherapy for gastroesophageal reflux disease

1 reference

12 December 2020

Low-dose antacids versus 400 mg cimetidine twice daily for reflux oesophagitis. A comparative, placebo-controlled, multicentre study

1 reference

12 December 2020

Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid

1 reference

12 December 2020

Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid

1 reference

12 December 2020

Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine/GERD Investigation Group

1 reference

12 December 2020

Treatment of reflux oesophagitis with ranitidine

1 reference

12 December 2020

Treatment of reflux esophagitis with H2-blockers, antacids and prokinetic drugs. An analysis of randomized clinical trials

1 reference

12 December 2020

Quantitation of Gastroesophageal Reflux Before and After Therapy Using the Gastroesophageal Scintiscan

1 reference

12 December 2020

Sucralfate therapy and reflux esophagitis: an overview

1 reference

12 December 2020

Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The U.S. multicenter study

1 reference

12 December 2020

Combination therapy of sucralfate and cimetidine, compared with sucralfate monotherapy, in patients with peptic reflux esophagitis

1 reference

12 December 2020

Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)

1 reference

12 December 2020

Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial

1 reference

12 December 2020

Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.

1 reference

12 December 2020

Treatment of severe reflux esophagitis with cimetidine and metoclopramide

1 reference

12 December 2020

Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine Treatment

1 reference

12 December 2020

Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux

1 reference

12 December 2020

Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s

1 reference

12 December 2020

Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease

1 reference

12 December 2020

Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.

1 reference

12 December 2020

Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring

1 reference

12 December 2020

Gastric alkalinization. Effect on lower-esophageal-sphincter pressure and serum gastrin

1 reference

12 December 2020

[Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium]

1 reference

12 December 2020

Rolling review: gastro-oesophageal reflux disease.

1 reference

12 December 2020

Ranitidine and placebo in the treatment of reflux oesophagitis. A double-blind randomized trial.

1 reference

12 December 2020

Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis

1 reference

12 December 2020

The clinical safety of omeprazole

1 reference

12 December 2020

Review article: drug therapy for reflux oesophagitis.

1 reference

12 December 2020

A Multicentric, Randomized Clinical Trial of Gaviscon in Reflux Esophagitis

1 reference

12 December 2020

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

1 reference

12 December 2020

Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

1 reference

12 December 2020

Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus

1 reference

12 December 2020

Rationale and efficacy of medical therapy for gastrooesophageal reflux disease

1 reference

12 December 2020

Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine

1 reference

12 December 2020

Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus

1 reference

12 December 2020

Comparison of the effect of sucralfate and ranitidine in reflux esophagitis

1 reference

12 December 2020

Healing of erosive esophagitis with sucralfate and cimetidine: influence of pretreatment lower esophageal sphincter pressure and serum pepsinogen I levels.

1 reference

12 December 2020

Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders

1 reference

12 December 2020

Medical therapy for gastroesophageal reflux disease

1 reference

12 December 2020

Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter trial.

1 reference

12 December 2020

Efficacy of famotidine 20 mg twice a day versus 40 mg twice a day in the treatment of erosive or ulcerative reflux esophagitis

1 reference

12 December 2020

Oral cimetidine in reflux esophagitis: a double blind controlled trial

1 reference

12 December 2020

Bethanechol or cimetidine in the treatment of symptomatic reflux esophagitis: a double-blind control study

1 reference

12 December 2020

Why do apparently healthy people use antacid tablets?

1 reference

12 December 2020

Gastroesophageal reflux disease. Acute and maintenance treatments with cimetidine

1 reference

12 December 2020

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2)

1 reference

12 December 2020

Healing and relapse of reflux esophagitis during treatment with ranitidine.

1 reference

12 December 2020

Cost and Quality Effects of Alternative Treatments for Persistent Gastroesophageal Reflux Disease

1 reference

12 December 2020

Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus

1 reference

12 December 2020

Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug

1 reference

12 December 2020

The medical management of reflux esophagitis. Role of antacids and acid inhibition

1 reference

12 December 2020

Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease

1 reference

12 December 2020

Sucralfate in the treatment of reflux esophagitis in adults: an update

1 reference

12 December 2020

A comparison of two doses of nizatidine versus placebo in the treatment of reflux oesophagitis

1 reference

12 December 2020

Symptomatic gastroesophageal reflux: incidence and precipitating factors

1 reference

12 December 2020

Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis

1 reference

12 December 2020

Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis

1 reference

12 December 2020

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

1 reference

12 December 2020

Clinical efficacy of pantoprazole compared with ranitidine

1 reference

12 December 2020

Clinical efficacy of sucralfate in reflux esophagitis. Comparison with cimetidine

1 reference

12 December 2020

Failure of sucralfate in the treatment of refractory esophagitis versus high-dose famotidine. An endoscopic study

1 reference

12 December 2020

Cisapride versus ranitidine in the treatment of reflux esophagitis.

1 reference

12 December 2020

Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial

1 reference

12 December 2020

Omeprazole in H2 receptor antagonist-resistant reflux esophagitis

1 reference

12 December 2020

Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole.

1 reference

12 December 2020

Treatment of reflux esophagitis with sucralfat

1 reference

12 December 2020

Controlled trial of cimetidine in reflux esophagitis

1 reference

12 December 2020

Sucralfate versus placebo in reflux esophagitis. A double-blind multicenter study

1 reference

12 December 2020

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

1 reference

12 December 2020

Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.

1 reference

12 December 2020

A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis

1 reference

12 December 2020

The rationale of acid suppression in the treatment of acid-related disease

1 reference

12 December 2020

Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease

1 reference

12 December 2020

10.2165/00003495-199549050-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

12 September 2017

1028997026

0 references

Fatcat ID

release_nilo4y7eabdexe7n2iqdhqx4ga

0 references

1 reference